Free Webex Call
The Syringes Market was valued at USD 15.02 Billion in 2024, and is expected to reach USD 20.69 Billion by 2030, rising at a CAGR of 5.68%. Syringes continue to be foundational tools in healthcare, widely used for delivering medications and vaccines across diverse settings including hospitals, clinics, ambulatory centers, and home care environments. Market expansion is strongly driven by the growing prevalence of chronic and infectious diseases such as diabetes, cardiovascular disorders, and respiratory illnesses that necessitate frequent injectable therapies. Additionally, expanding healthcare infrastructure and rising patient populations are propelling demand. However, environmental sustainability concerns related to plastic waste, pricing pressures in lower-income regions, and risks from counterfeit or low-quality products pose challenges to market growth. Despite these barriers, innovations in product design and increased home-based care are expected to bolster future demand for syringes globally. Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Key Market Drivers
Growth in Healthcare Industry
The accelerating growth of the global healthcare industry - accounting for over USD 4 trillion in annual sales - has become a central driver for the syringes market. Key sectors such as pharmaceuticals, biotechnology, diagnostics, and medical technology are all contributing to increased demand for precise and efficient drug delivery systems. The expanding incidence of noncommunicable diseases (NCDs) like diabetes, cancer, and cardiovascular ailments, which in 2021 accounted for 75% of global non-pandemic-related deaths, underscores the growing need for injectable therapies. With 82% of premature NCD deaths occurring in low- and middle-income countries, the global reliance on injectable drug delivery tools like syringes has intensified. These devices are essential for subcutaneous and intravenous medication administration, especially for chronic disease management, driving robust and sustained market demand.Key Market Challenges
Rise in Environmental Concerns
Environmental sustainability has become a growing concern in the syringes market due to the widespread use of single-use plastic syringes, which contribute significantly to global medical waste. Billions of syringes are used annually, and improper disposal - especially in countries with underdeveloped waste management infrastructure - poses risks to public health and ecosystems. The accumulation of non-biodegradable plastic waste from disposable syringes contaminates landfills, water bodies, and surrounding environments. As pressure mounts from environmental agencies and governments to implement greener practices, manufacturers and healthcare providers face the challenge of balancing infection control with sustainable material usage, which may involve transitioning to recyclable or biodegradable alternatives or adopting improved waste management protocols.Key Market Trends
Expansion of Home Healthcare and Self-Administration
The global shift toward patient-centric care is boosting the home healthcare sector and increasing the prevalence of self-administered treatments, directly influencing the syringes market. India’s home healthcare industry, for instance, grew to USD 5.4 billion and is expected to reach nearly USD 20 billion by 2025. This trend reflects a broader global pattern in which patients with chronic diseases such as diabetes, rheumatoid arthritis, and hormonal conditions increasingly manage treatments at home. Demand for user-friendly, safe, and reliable syringes - such as prefilled syringes, autoinjector-compatible formats, and safety-engineered devices - is rising. These products enhance ease of use, minimize dosing errors, and reduce needle-stick injuries, making them ideal for non-clinical environments and supporting improved treatment adherence and outcomes.Key Market Players
- Becton, Dickinson, and Company
- Terumo Corporation
- Medtronic plc
- B. Braun Medical Inc.
- Nipro Corporation
- Hindustan Syringes & Medical Devices Ltd.
- Gerresheimer AG
- SCHOTT AG
- CODAN Medizinische Geräte GmbH
- Baxter Healthcare Corporation
Report Scope
In this report, the Global Syringes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:Syringes Market, By Material:
- Plastic
- Glass
Syringes Market, By End Use:
- Hospitals & Clinics
- Blood Collection Centers
- Ambulatory Care Centers
- Others
Syringes Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Syringes Market.Available Customizations
With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.Company Information
- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
1. Product Overview
2. Research Methodology
3. Executive Summary
5. Global Syringes Market Outlook
6. North America Syringes Market Outlook
7. Europe Syringes Market Outlook
8. Asia Pacific Syringes Market Outlook
9. South America Syringes Market Outlook
10. Middle East and Africa Syringes Market Outlook
11. Market Dynamics
12. Market Trends & Developments
15. Porters Five Forces Analysis
16. Competitive Landscape
Companies Mentioned
- Becton, Dickinson, and Company
- Terumo Corporation
- Medtronic plc
- B. Braun Medical Inc.
- Nipro Corporation
- Hindustan Syringes & Medical Devices Ltd.
- Gerresheimer AG
- SCHOTT AG
- CODAN Medizinische Geräte GmbH
- Baxter Healthcare Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 185 |
Published | June 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 15.02 Billion |
Forecasted Market Value ( USD | $ 20.69 Billion |
Compound Annual Growth Rate | 5.6% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |